Rupam Manna/LinkedIn
Jul 19, 2026, 16:59
Rupam Manna: Not All Portal Vein Involvement in HCC Is the Same
Rupam Manna, Postdoctoral Student – DrNB Medical Oncology at National Board of Examinations, shared a post on X:
“Not all portal vein involvement in HCC is the same.
The Vp classification helps define the extent of portal vein tumor thrombosis (PVTT) – one of the most important factors influencing prognosis and treatment strategy in hepatocellular carcinoma.
- Vp0–Vp2: Early vascular involvement where selected patients may still benefit from surgery or locoregional therapies.
- Vp3–Vp4: Major portal vein invasion, usually requiring systemic therapy, with Y-90 radioembolization (TARE) emerging as an important option in carefully selected patients.
Understanding the anatomy of portal vein invasion is key to making the right therapeutic decision.
Save this infographic for a quick review and share it with colleagues interested in liver cancer.”

Stay updated with Hemostasis Today.
-
Jul 20, 2026, 12:54Victor Emmanuel: Preventing Severe Maternal Complications Associated With Anemia
-
Jul 20, 2026, 12:33Ney Carter Borges: The Evolving Role of Aspirin in Coronary Artery Disease
-
Jul 20, 2026, 12:15Zain Khalpey: Why the Cause of Reduced Perfusion Matters
-
Jul 20, 2026, 11:53ISTH 2026 Showcases Landmark Research and Launches Women’s Health Hub
-
Jul 20, 2026, 10:40Omid Seidizadeh: Advancing Genomic Insights into Bleeding Disorders at ISTH 2026
-
Jul 20, 2026, 10:30Marc Blondon: What Are the Current Practices For VTE Prevention in Pregnancy Worldwide?
-
Jul 20, 2026, 10:11Zeyad Bady: Advancing Thrombosis Research on the International Stage at ISTH 2026
-
Jul 20, 2026, 09:41Emily Bury: From Emerging Evidence to Better Patient Care at ISTH 2026
-
Jul 20, 2026, 08:58Samantha Pasca: Insights into Pain and Coping in Hemophilia at ISTH 2026